The FDA approved 20 new molecular entity NDAs in the first half of 2011, which is an impressive coun
Bruce Booth, Forbes
Wed, 07/27/2011 - 9:28am
The FDA approved 20 new molecular entity NDAs in the first half of 2011, which is an impressive coun